Trial Profile
Monitoring of Vedolizumab Infusion Therapy response with fecal calprotectin, ultrasound and trough serum level in Ulcerative colitis. A multicentric, prospective non-interventional Study - MOVE-IT
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms MOVE-IT
- 21 May 2019 Status changed from not yet recruiting to recruiting.
- 12 Nov 2018 New trial record